Clinical Trials Logo

Lipid Metabolism, Inborn Errors clinical trials

View clinical trials related to Lipid Metabolism, Inborn Errors.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT05425745 Active, not recruiting - Clinical trials for Hypercholesterolemia

Evaluate the Effect of Obicetrapib in Patients With HeFH on Top of Maximum Tolerated Lipid-Modifying Therapies.

BROOKLYN
Start date: July 25, 2022
Phase: Phase 3
Study type: Interventional

This study will be a placebo-controlled, double-blind, randomized, phase 3 study to Evaluate the Efficacy, Safety, and Tolerability of Obicetrapib in Participants with a History of Heterozygous Familial Hypercholesterolemia (HeFH).

NCT ID: NCT02635269 Active, not recruiting - Clinical trials for Glycogen Storage Disease Type II

Fat and Sugar Metabolism During Exercise in Patients With Metabolic Myopathy

Start date: January 2016
Phase: N/A
Study type: Interventional

This study aims to characterize the pathophysiological mechanisms of 21 different metabolic myopathies. The study will focus on exercise capacity and the metabolic derangement during exercise.